Related Experiment Videos
Completion thyroidectomy for malignancy after initial minimal access thyroid surgery.
Michael W Yeh1, Stan B Sidhu, Mark Sywak
1Department of Surgery, University of Sydney Endocrine Surgical Unit, Royal North Shore Hospital, Sydney, New South Wales, Australia.
ANZ Journal of Surgery
|June 14, 2006
Summary
Completion thyroidectomy after minimal access thyroid surgery (MATS) is safe. This study found no increased complications or poorer cosmetic outcomes compared to conventional surgery, making MATS a viable option for malignancy.
Area of Science:
- Endocrine Surgery
- Surgical Oncology
- Thyroid Cancer Treatment
Background:
- Minimal access thyroid surgery (MATS) offers cosmetic benefits for small thyroid nodules.
- Completion thyroidectomy after MATS for malignancy may require incision conversion and re-operation in a previously dissected area.
Purpose of the Study:
- To compare complication rates and cosmetic outcomes of completion thyroidectomy for malignancy after MATS versus conventional hemithyroidectomy.
Main Methods:
- Retrospective cohort study of patients undergoing completion thyroidectomy for malignancy.
- Data collected from January 2002 to January 2005.
- Outcome measures included complication rates, final scar length, and patient scar appearance satisfaction.
Main Results:
- No significant difference in complication rates between MATS and conventional hemithyroidectomy groups.
- Complications observed were flap edema (control) and keloid scar (MATS).
- Mean final incision length, scar appearance, and patient satisfaction were similar between groups.
Conclusions:
- Completion thyroidectomy for malignancy following MATS does not present a demonstrable disadvantage.
- MATS is a safe and effective approach even when subsequent completion thyroidectomy is necessary.